Skip to main content

JPMORGAN CHASE & CO

Position in VKTX — Viking Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$15,804,773
-$3,432,634 QoQ
Shares Held
485,703
-11.2% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 82.11026079723617.ToString("F0")% Shared 0.ToString("F0")% None 17.88973920276383.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. VKTX ranks #62 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,804,773 485,703
2025-12-31 $19,237,407 546,828
2025-09-30 $67,725,843 2,577,087
2025-06-30 $69,934,956 2,639,055
2025-03-31 $75,505,020 3,126,502
2024-12-31 $86,819,527 2,157,543
2024-09-30 $133,991,686 2,116,438
2024-06-30 $119,361,076 2,251,671
2024-03-31 $85,292,956 1,040,158
2023-12-31 $10,562,885 567,592
2023-09-30 $6,167,848 557,168
2023-06-30 $8,859,299 546,533
2023-03-31 $43,921 2,638
2022-12-31 $4,681 498
2022-09-30 $78,901 29,008
2022-06-30 $133,184 46,085
2022-03-31 $98,679 32,893
2021-12-31 $125,518 27,287
2021-09-30 $164,126 26,135
2021-06-30 $160,962 26,872
2021-03-31 $249,349 39,423
2020-12-31 $167,772 29,800
2020-09-30 $142,252 24,442
2020-06-30 $158,994 22,052
2020-03-31 $100,408 21,455